Laboratoires Vivacy Revenue and Competitors
Employee Data
- Laboratoires Vivacy has 225 Employees.
- Laboratoires Vivacy grew their employee count by 46% last year.
Laboratoires Vivacy's People
Name | Title | Email/Phone |
---|
Laboratoires Vivacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 80 | 7% | N/A | N/A |
#2 | N/A | 445 | -2% | N/A | N/A |
#3 | N/A | 140 | -12% | N/A | N/A |
#4 | N/A | 225 | 46% | N/A | N/A |
#5 | $15M | 277 | 30% | N/A | N/A |
#6 | $1.7M | 445 | -2% | N/A | N/A |
#7 | N/A | 262 | 40% | N/A | N/A |
#8 | N/A | 65 | 2% | N/A | N/A |
#9 | N/A | 78 | 30% | N/A | N/A |
What Is Laboratoires Vivacy?
Laboratories VIVACY is a French manufacturer specialising in the design, production and distribution of high quality injectable medical devices for use in the field of Anti-ageing, especially in Medical Aesthetics and Viscosupplementation.Founded in 2007 by specialists qualified in biopolymers and injectable product technologies with more than 25 years’ experience in the field, the company has acquired recognised expertise in dermal fillers based on hyaluronic acid and natural antioxidants, mannitol and sorbitol. The company has also created new technologies for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®), gynecology (DESIRIAL®) and is currently developing in other medical viscosupplementation fields.Thanks to its strong international distribution network, Laboratoires VIVACY is present on the medical aesthetics market in over 80 countries. http://www.vivacy.eu/http://www.stylage.eu/http://www.desirial.eu/http://stylage-skinpro.com/
keywords:N/AN/A
Total Funding
225
Number of Employees
N/A
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35.9M | 225 | N/A | N/A |
#2 | $72.1M | 226 | 6% | N/A |
#3 | $52.2M | 226 | 3% | N/A |
#4 | N/A | 227 | 19% | N/A |
#5 | $61.7M | 228 | 6% | N/A |